Northern Light Venture Capital

Northern Light Venture Capital, established in 2005 by Feng Deng and Yan Ke, is a venture capital firm headquartered in Menlo Park, California, with a strong focus on China. The firm manages approximately $1.5 billion in committed capital across multiple funds, including both US and RMB funds, and has invested in over 180 portfolio companies. It specializes in early and growth stage investments, particularly in sectors such as information technology, healthcare, consumer services, and clean technologies. The management team comprises experienced executives, including Feng Deng and Yan Ke, who bring significant expertise from their backgrounds in technology and venture capital. Northern Light aims to identify and nurture innovative and disruptive business opportunities that leverage China's resources to create enduring enterprises in the global market. Notable portfolio companies include Meituan.com, Kaixin001.com, and Gogo.com.

Freeman Ding

Executive Director

Jiang Haotian

Managing Director

Elton Jiang

Managing Director

Yan Ke

Venture Partner and Co-Founder

Lixin Li

Venture Partner

Stella Li

Partner

Ray Yang Ruirong

Managing Director

Simon Sun

Venture Partner

Zhi Tan

Venture Partner

Victor Tsao

Venture Partner

Zheng Wei

Venture Partner

John Wu

Venture Partner

Tony Wu

Partner

Ben Yan

Partner

Fiona Yu

Partner

Johnny Zhang

Vice President

400 past transactions

ECTEK

Post in 2023
Changzhou ECTEK Automotive Systems CO., Ltd researches, develops, manufactures, and sells electrical automotive products. The company offers vehicle control systems, test bench and control systems, electronic control unit (ECU) test systems, and diesel electric control systems. Changzhou ECTEK Automotive Systems CO., Ltd supplies its products to marine, locomotive, construction machinery, and other power industries. The company was founded in 2005 and is based in Changzhou, China.

Surpath

Seed Round in 2022
Surpath is an AI-driven cloud-based platform that formulates optimal supply chain solutions based on clients' needs. The firm provides cross-border transportation to destination services, optimized logistics, and analytics solutions that solve complex problems.

BUD

Series B in 2022
Founded in 2019 by former Snap engineers, Risa Feng and Shawn Lin, Singapore-headquartered BUD is a leading global metaverse UGC platform encouraging users to create and share 3D interactive experiences with its easy-to-use creation tools. Since its global launch in November 2021, BUD skyrocketed to the list of top 10 social apps in more than 38 countries around the world including North America, Southeast Asia and South America. Millions of 3D content has been created and traded on the platform. BUD has become a digital social hub where millions of people come to create, play and hangout.

Point One

Series B in 2022
Building the next-gen consumer products!

Jingwei Shida

Series A in 2022
Jingwei Shida is a medical equipment R&D and supplier, focusing on the research and development of optoelectronic medical equipment.

CSR Biotech

Seed Round in 2022
Guangzhou Chaoshiji Biotechnology Co., Ltd. (Chaoshiji Technologies) is a high-tech company specializing in the creation and deployment of super-resolution imaging devices for living cells. R&D, production, sales, after-sales, and technical output services for various types of super-resolution optical microscopes are the primary activities. Among the services offered are customized cell sample generation, customized cell sample high-throughput detection, customized cell sample imaging studies, and customized image post-processing and quantitative analysis.

Huahuixin Group

Series B in 2022
"Huahuixin" was established in 2017. Its core capabilities are the design, development and production of micro-nano structured optical chips and laser chips, which are in the upstream chip manufacturing link of the optoelectronics industry. There are two main business models: on the one hand, relying on high-end optoelectronic chip technology capabilities to provide joint R&D and foundry services for optoelectronic chip design companies; on the other hand, based on the team's technical capabilities in micro-nano structured optical chips and laser chips, Independent research and development, design and large-scale production of optoelectronic products.

Zhonghui Laser

Series A in 2022
Zhonghui Laser is an emerging technology company dedicated to the development and manufacture of advanced lasers.

Xinrui Medical

Angel Round in 2022
Xinrui Medical is a domestic enterprise that engages in the research and development of polymer valves. It focuses on new polymer valves to build a complete solution for heart valve disease. The team members have long been engaged in the research and development of polymer synthesis and polymer-related medical devices. They are all from well-known medical device companies and have complete product development experience and mature industrialization thinking.

Binance.US

Seed Round in 2022
Binance.US operates a regulated cryptocurrency exchange that allows users to buy, sell, and trade a variety of digital assets. The platform is designed to promote financial confidence and enhance cryptocurrency literacy among its users. It leverages advanced technology to provide a fast, secure, and reliable trading experience, while maintaining low trading fees and transaction costs. As a FinCEN regulated entity, Binance.US aims to support the transition to a digital economy in the United States, making it accessible for everyday users to engage with cryptocurrencies.

Xmov

Series C in 2022
Xmov is an AI company focusing on computer vision and computer graphics.

Nanovision

Venture Round in 2022
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base with an additional subsidiary in Chengdu, specializes in high-speed and high-precision radiology imaging. The company focuses on the development of static CT, X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision created China's first self-developed CMOS flat panel detector, known as the Merak series. Its products are applicable in various sectors, including medical, industrial, and security, offering advanced technological support both domestically and internationally. With a significant research and development foundation, Nanovision is positioned as a key player in the radiation imaging industry.

Yudao Bio

Series A in 2022
Shanghai Yudao Biotechnology Co., Ltd. is a biopharmaceutical company established in 2013, headquartered in Shanghai, China. The company specializes in the development of platforms for drug development, alongside offering medical bioinformatics training. Through its innovative approaches, Yudao Bio aims to enhance biopharmaceutical products and contribute to advancements in the healthcare sector.

HemaCell

Seed Round in 2022
HemaCell is a cell therapy company specializing in the in vitro regeneration of hematopoietic lineages, including blood and immune cells. Founded by experts with extensive experience in the field, the company utilizes advanced stem cell reprogramming and differentiation technologies to develop innovative solutions. HemaCell is focused on addressing the pressing demand for platelets in the treatment of various conditions, such as cancer, liver disease, critical illnesses, and hematological disorders. Additionally, the company is dedicated to creating new therapeutic drugs targeting diseases associated with platelet abnormalities, thereby offering effective treatment options for patients.

Ucello Therapeutics

Series A in 2022
Ucello Therapeutics focuses on the development of allogeneic cell therapies utilizing its proprietary CAR-T cell technology platform, known as CBT-X20. The company aims to create universal CAR-T cell therapeutic drugs that address unmet clinical needs in cancer treatment. By leveraging advanced gene and cell therapy technologies, Ucello's therapies target cancer cells at the molecular level, making them accessible to patients with varying lymphocyte levels and those with a history of transplant relapse. This innovative approach allows for effective cancer gene therapies to be administered to individuals with specific pre-existing medical conditions.

Mindfront Health

Seed Round in 2022
Mindfront Health is a mental health company based in Shanghai, China, specializing in comprehensive diagnosis and treatment through evidence-based psychotherapy services. Established in 2020 as a brand under Luye Life Sciences Group, Mindfront Health operates a chain of psychiatric facilities across major cities, including Shanghai, Shenzhen, Guangzhou, and Xi'an. The company employs a dual approach that combines evidence-based drug treatments with non-drug interventions, aimed at addressing various mental health issues such as depression, sleep disorders, ADHD, and gaming addiction. Mindfront Health is committed to creating personalized treatment systems that cater specifically to the needs of the Chinese population, and it also offers an internet medical service platform to enhance accessibility. Through strategic collaborations with local institutions and leveraging Luye's clinical services, Mindfront Health aims to replicate its model at scale, providing holistic mental health solutions to its patients.

H-CHIP TECH

Venture Round in 2022
H-CHIP TECH is a high-end optoelectronic research and development company based in Tianjin, China. It focuses on the development of micro-nano optoelectronic chips for industrial clients, particularly in the realm of distributed feedback (DFB) semiconductors. The company's expertise lies in creating advanced optoelectronic chips that provide reliable technological support for the optical communication industry, catering to the growing demand for innovative solutions in this field.

OUTPUT

Venture Round in 2022
OUTPUT is a creative platform for the innovation of digital experiences. It features cutting-edge digital artists, designers, and developers across the globe, initiating cross-industrial practices online and offline, updating multi-dimensional experiences generated by digital art and design, and nurturing a central hub for generative dialogues via digital experiences.

CATUG Biotechnology

Venture Round in 2022
CATUG is focused on the development and application of new biomedical technologies. It provides one-stop CDMO services for the entire industry chain from quality research and clinical application to industrialization. It has R&D centers and industrialization bases in Suzhou and Wuhan.

Wancheng Gene

Series A in 2021
Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

Kind Pharmaceutical

Series B in 2021
Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs. The company was founded in 2013 and is headquartered in Redwood City, California, United States.

Novlead Biotech

Series B in 2021
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

Stellar Cyber

Series B in 2021
Stellar Cyber is an automated detection and response (Open-XDR) platform that correlates detections from existing solutions as well as its own security applications to deliver comprehensive protection across the cybersecurity kill chain and present them through one intuitive dashboard. Customers can leverage 20 native applications and a growing list of open ecosystem partners to detect and respond automatically to attacks within seconds wherever they occur on servers, in the network, at endpoints, or in cloud-based applications. Stellar Cyber deploys easily on premises, in public clouds or with service providers.

TenaFe

Series B in 2021
TenaFe, Inc. is a company that specializes in the development of solid-state drive (SSD) controllers aimed at enhancing data storage solutions across various applications, including client devices, data centers, and emerging edge technology. Founded in 2018 and headquartered in Campbell, California, TenaFe is recognized for its patented technology that significantly improves the reliability, performance, and energy efficiency of SSDs. The company’s innovative solutions cater to a diverse range of devices, from connected gadgets to personal computers and data centers, addressing critical data storage challenges while enabling clients to benefit from superior storage reliability and energy efficiency.

RiVAI

Series A in 2021
Developer of an artificial intelligence chip based on RISC-V(an open standard instruction set architecture based on established reduced instruction set computer principles) technology for IoT(Internet of Things) applications. The company's products can be used in a variety of IoT/AIoT application scenarios such as wearable devices, smart homes, smart security, agriculture, and consumer electronics, enabling clients to have low-power, high-performance core processor chips
It provides mobile enterprise resource planning(ERP) systems for sales, production and storage management.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

Bombax

Series A in 2021
Xiaoice is an AI company that develops a chatbot that acts as a digital assistant with the capability to understand human conversations. Xiaoice allows cross-platform interactions, enabling users to enjoy the convenience of artificial intelligence. Xiaoice is designed as a teenage girl and is touted as an empathic computing framework focusing on longer back-and-forth conversations with humans instead of simply answering questions or obeying commands like most bots. Its technology covers natural language processing, computer voice, computer vision, and AI content generation.

Orient Speech Therapy

Series C in 2021
Provider of speech and language therapy services intended for stunted children with speech disorder. The company provides early screening, clinical diagnosis, and therapeutic interventions to children with autism or speech disorder, enabling children to speak and communicate better.

Micot

Series B in 2021
Shaanxi Micot Technology Co. Ltd specializes in the development of peptide drugs and innovative biopharmaceuticals. Founded in 2007 and based in Xi'an, China, the company focuses on creating treatments for various diseases, including cancer, cardiovascular, cerebrovascular, and neurological conditions. Micot's research includes the development of multi- and protein-based therapies, vaccines, and biomolecular drug delivery systems. Notably, the company has developed a unique biological macromolecular respiratory drug delivery system, Bio-Res-Deliv, which is designed for treating cardiovascular diseases, metabolic disorders, and liver diseases. Through its innovative approaches, Micot aims to advance drug screening and biopharmaceutical research.

Omnisensing Photonics

Series A in 2021
Omnisensing Photonics specializes in the development of advanced laser sensing technology that leverages photonics integrated circuits and coherent communication. The company focuses on creating high-performance, cost-effective LiDAR solutions suitable for a range of large-scale applications, including precision manufacturing, machine vision, and autonomous driving. By innovating within the realm of industrial 3D technologies, Omnisensing aims to redefine standards and enhance capabilities in these emerging fields.

Speedaf

Series A in 2021
Speedaf Logistics Limited specializes in integrated logistics and transportation services primarily between China and Africa. Founded in 2019 and headquartered in Shenzhen, China, the company offers a comprehensive range of services, including air, sea, and road transportation, as well as warehousing, packaging, and labeling. Speedaf aims to optimize logistics costs and enhance efficiency through its platform, which provides order information and online tracking services. With additional offices in Ghana, Nigeria, Kenya, and Uganda, Speedaf positions itself as a one-stop logistics service provider, delivering stable and recognized supply chain solutions to its clients in the region.

LuxCreo

Series B in 2021
LuxCreo, founded in 2016, specializes in large-scale 3D printing manufacturing, encompassing software, hardware, and materials. The company offers a comprehensive 3D printing and software development platform that aims to enhance production efficiency in the manufacturing sector while simultaneously reducing costs for enterprises. LuxCreo develops innovative 3D printing equipment and provides services that include software and electronic hardware development, as well as material development. By leveraging advanced additive manufacturing techniques, LuxCreo addresses the growing demand for efficient and effective 3D printing solutions across various industries.

Next Generation Gene Therapeutics

Series A in 2021
Next Generation Gene Therapeutics is a healthcare company that engages in the research and development of gene therapy. Its unique propriety technology of "one target and two bullets" can provide effective treatment for a variety of genetic diseases that currently have few therapeutic methods in the world. NGGT was founded in March 2020 by senior scientists and entrepreneurs in the field of gene therapy. It is committed to becoming the world's leading gene therapy company with international influence. The company has successful experience in the whole industry chain, concerning the early development of gene therapy products, the large-scale production of viral vectors, the construction of quality standards, international multi-center clinical research, and the application for the marketing of gene therapy products.

InnoStar Semiconductor

Seed Round in 2021
InnoStar Semiconductor is a semiconductor storage technology service company.

Brattea

Series B in 2021
Brattea is a medical device research and development company specializing in renal denervation products aimed at treating conditions such as hypertension, cancer pain, and diabetes. The company develops interventional devices, including renal artery ablation catheters and radiofrequency ablation equipment, as well as medical mapping systems. These products are designed to address a range of health issues, including refractory hypertension, obstructive sleep apnea, kidney disease, and heart failure. Brattea is committed to providing reliable medical solutions that enhance patient care and improve health outcomes.

Immune-Onc Therapeutics

Series B in 2021
Immune-Onc Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, founded in 2016. The company specializes in the discovery and development of innovative biologic therapies aimed at treating cancer. Immune-Onc Therapeutics focuses on the tumor microenvironment and immune suppressive pathways, utilizing advanced scientific insights to create novel immuno-oncology products. The company employs a targeted approach to develop first-in-class therapeutic antibodies that disarm immune suppression in tumors, thereby enhancing the immune response against cancer. Through its differentiated pipeline, Immune-Onc Therapeutics aims to provide new treatment options for cancer patients, addressing critical needs in the field of immunology and oncology.

MediTrust Health

Series B in 2021
Shanghai MediTrust Health Technology Co., Ltd. provides help to patients solve its medical expenses through financial insurance. The firm is based in Shanghai, China.

Minayo

Seed Round in 2021
Minayo is a food company specializing in the manufacture and distribution of health supplements and functional snacks. The company aims to enhance consumer health and performance by offering products that are both nutritious and convenient. Through its focus on functional snacks and nutritional supplements, Minayo provides options that cater to health-conscious individuals seeking to improve their overall well-being.

Teon Therapeutics

Series A in 2021
Teon Therapeutics is a clinical-stage biopharmaceutical company dedicated to improving the lives of cancer patients by developing a focused portfolio of small molecules that inhibit the immunosuppressive and cancer-promoting signaling pathways in the tumor microenvironment. Teon's lead program is an A2BR-specific antagonist that will enter Phase1b trials in 2021.

Singular Medical

Series B in 2021
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Neurophth

Series B in 2021
Wuhan Neurophth Biotechnology Co., Ltd. is a pioneering ophthalmology gene drug research and development company based in Wuhan, China, established in 2008. It focuses on gene therapies for ocular genetic diseases, with a particular emphasis on Leber hereditary optic neuropathy (LHON), a condition caused by genetic mutations. Neurophth has made significant advancements in the field, completing the world's first clinical study of gene therapy for LHON in 2011, which involved nine patients and has since observed their progress over seven years. The company aims to develop effective treatments for various ophthalmic disorders, including degenerative optic nerve injuries and vascular retinopathy, thereby providing physicians with innovative therapeutic options for patients suffering from these conditions.

Orient Speech Therapy

Series C in 2021
Provider of speech and language therapy services intended for stunted children with speech disorder. The company provides early screening, clinical diagnosis, and therapeutic interventions to children with autism or speech disorder, enabling children to speak and communicate better.

magAssist

Series B in 2021
Suzhou MagAssist Medical Technology Co., Ltd. is a Chinese company specializing in the development of short and medium-term in vitro ventricular assist devices, commonly referred to as in vitro artificial hearts. Founded in 2016 and based in Suzhou, the company aims to provide innovative solutions for patients experiencing severe cardiovascular conditions, including those recovering from cardiopulmonary bypass and acute illnesses such as fulminant myocarditis and cardiac arrest. MagAssist focuses on integrating advanced fluid mechanics and magnetic suspension technology into its products to enhance compatibility with various blood types, thereby improving patient recovery outcomes. The company is recognized for its homegrown artificial heart technology, backed by a team of experts with extensive experience in artificial heart research and development.

Picky

Pre Seed Round in 2021
Picky is a mobile-first community that enables consumers to discover the best skincare and beauty brands and products that are right for them through extensive user reviews, educational content, and experts’ contributions. With a focus on authenticity, education, and personalization, its community creates and consumes content about skincare and beauty, including K-beauty. Picky’s platform includes a Skin Type Analyzer, a one-minute tool that determines skin type with 14 easy questions. Based on the answers, users can discover the characteristics of their personal skin type and select what works best for them. The database, which is updated regularly, includes over 40,000 products from evergreen favorites to newly-launched indie K-beauty brands.

VesiCURE

Venture Round in 2021
VesiCURE Therapeutics is a company dedicated to the research and development of innovative exosome-based drugs. Founded in 2021 and located in Suzhou, Jiangsu, China, VesiCURE aims to advance the exosomal pharmaceutical industry by focusing on the creation and enhancement of exosomal therapies. The company's efforts are centered on harnessing extracellular vesicles to develop new drug formulations, thereby contributing to the evolution of this emerging sector in medicine.

Novlead Biotech

Series A in 2021
Novlead Biotech contributes to a safer and healthier human well-being through our technological innovations.

Genfleet

Venture Round in 2021
GenFleet Therapeutics, based in Shanghai, China, is a biotechnology company focused on the research and development of therapeutic molecules aimed at cancer treatment. Founded in 2017, the company specializes in creating innovative pharmaceuticals and antibody drugs that target various cancer systems. Its efforts are directed at reactivating tumor-specific immune responses and mobilizing the body's own immune system to combat cancer. GenFleet Therapeutics serves both domestic and international markets, contributing to advancements in cancer therapy through its development of signal transduction regulators, tumor microenvironment modulators, and transcription factors.

Genepoint

Venture Round in 2021
Genepoint Biological Technology (China) Co., Ltd. is a Shanghai-based company that specializes in the manufacturing of devices for cryogenic biomaterial storage and handling. Its product line includes Automated Cryo-Bio Storage systems, Plugged Hybrid Cryo-Storage units, LIN Vapor Freezers, and hoists designed for freezer operations. These products are primarily aimed at life sciences researchers, facilitating the safe and efficient storage of biological materials at low temperatures.

Applied Cells

Venture Round in 2021
Applied Cells creates a revolutionary solution to complete the workflow of cell separation and enrichment products. It helps in battles against cancer by providing tools that are not only capable of isolating the rarest cancer cells but also capable of extracting the highest quality immune cells to achieve better cell therapy outcomes. It was founded in 2017 and is based in Santa Clara, California.

Diyi International Logistics

Venture Round in 2021
CNE invests in order to develop the sectors operational productivity, has developed an advanced integrated support service platform separately, and provides employment of automatic process sorting devices to attain an intelligent, efficient, and service company process. CNE has handled tens of thousands of cross-border e-commerce sellers and is the largest provider of inter-e-commerce logistics operations.

JAKA

Venture Round in 2021
JAKA Biotech is a manufacturer based in MinHang District, Shanghai, China, specializing in cosmetic functional raw materials. Founded in 2010, the company is dedicated to delivering effective skincare solutions through its expertise in plant extraction, fermentation, and synthesis. JAKA Biotech focuses on providing high-quality active ingredients that enhance skin beauty, utilizing advanced technology to create innovative raw materials for cosmetic production. Through its commitment to quality and efficacy, JAKA Biotech aims to meet the demands of clients in the cosmetic industry.

SaintSages

Venture Round in 2021
SaintSages is a minimally invasive energy device enterprise. The company is headquartered in Shanghai, China.

Power Site

Venture Round in 2021
Power Site is a modern technology enterprise that supplies X-ray imaging core components. It mainly provides high-voltage generators (HVG), combined X-ray sources, power distribution units (PDU), and other core components overall solutions for X-ray imaging systems. The products are mainly used in high-end X-ray imaging systems such as CT, DR, mammography, C-arm, CBCT, security inspection, industrial inspection, etc. The company has an advanced and efficient manufacturing platform with an annual production capacity of 50,000 units.

GiantMed Diagnostics

Venture Round in 2021
GiantMed Diagnostics is a third-party medical laboratory that specializes in the screening and diagnosis of complex eye diseases. Focused on precision ophthalmology, the company offers comprehensive testing services that include etiological testing, medical advice, medical consultations, and opportunities for scientific research collaboration. By providing a one-stop service for clinicians and patients, GiantMed Diagnostics aims to enhance the understanding and management of conditions such as uveitis and retinal choroidal diseases, thereby improving patient outcomes in the field of ophthalmology.

Biobiggen

Venture Round in 2021
Biobiggen is a non-invasive prenatal chromosomal disease and monogenic disease simultaneous screening technology platform. It is focusing on the pregnancy and childbirth period, focusing on prenatal screening, supplemented by newborn screening and prenatal diagnosis, and deeply creating the most complete high-throughput prevention and control of genetic diseases and birth defects Sequencing technology series of innovative products, leading enterprises and unicorn enterprises in the subdivision field. The company is headquartered in Beijing Economic and Technological Development Zone, has an overseas research center in Houston, the United States, and an R&D transformation center, GMP production base, and medical testing laboratory in Beijing.

Yunyinggu

Series D in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

BSPK

Series A in 2020
BSPK, Inc. operates a digital platform aimed at enhancing the shopping experience for luxury brands and their clients. Founded in March 2017 and based in Menlo Park, California, the platform allows sales advisers to communicate directly with customers through various channels, including websites, in-store interactions, mobile devices, and video streaming. By providing access to product images and sales data, BSPK empowers luxury retail associates to create personalized connections with clients, ultimately improving client retention and driving sales. The company focuses on enabling luxury brands to manage client data effectively, thereby enhancing the overall client-brand experience.

BSPK

Series A in 2020
BSPK, Inc. operates a digital platform aimed at enhancing the shopping experience for luxury brands and their clients. Founded in March 2017 and based in Menlo Park, California, the platform allows sales advisers to communicate directly with customers through various channels, including websites, in-store interactions, mobile devices, and video streaming. By providing access to product images and sales data, BSPK empowers luxury retail associates to create personalized connections with clients, ultimately improving client retention and driving sales. The company focuses on enabling luxury brands to manage client data effectively, thereby enhancing the overall client-brand experience.

Brosmed

Series C in 2020
BrosMed Medical Co., Ltd. engages into medical equipment. The firm was founded in 2012 and is based in China.

Reworld

Series B in 2020
Reworld is a platform offering training and IT tools that allow users to design their own videogames.

MemVerge

Series B in 2020
MemVerge specializes in memory storage convergence software that integrates memory and storage to enhance data processing capabilities. The company's innovative platform utilizes proprietary Distributed Memory Objects (DMO) technology, creating a logical convergence layer that leverages Intel's Optane DC persistent memory. This technology allows data-intensive workloads, including artificial intelligence, machine learning, big data analytics, and IoT applications, to operate at memory speed, ensuring data consistency across various systems. By enabling enterprises to manage both small and large files efficiently, MemVerge empowers organizations to extract insights from their data more effectively.

TenaFe

Series A in 2020
TenaFe, Inc. is a company that specializes in the development of solid-state drive (SSD) controllers aimed at enhancing data storage solutions across various applications, including client devices, data centers, and emerging edge technology. Founded in 2018 and headquartered in Campbell, California, TenaFe is recognized for its patented technology that significantly improves the reliability, performance, and energy efficiency of SSDs. The company’s innovative solutions cater to a diverse range of devices, from connected gadgets to personal computers and data centers, addressing critical data storage challenges while enabling clients to benefit from superior storage reliability and energy efficiency.

Yunyinggu

Series C in 2020
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

BlueX Micro

Series A in 2020
BlueX Microelectronics Corp. Ltd, a fabless semiconductor company, designs, develops, and markets ultra-low power wireless systems-on-chip and analog semiconductors for Internet of Things (IoT) and wearable applications. Its products are used in various applications, including IoT, wearable devices, consumer electronics, intelligent sports equipment, wireless medical, remote control, security, and toys. The company is based in Hefei, China.

Xinpletek

Series A in 2020
Xinpletek is a company based in Shanghai, China, that specializes in the design and development of radio frequency (RF) front-end solutions. The firm focuses on RF technology research and development, providing a range of RF front-end modules for applications in mobile phones, Internet of Things (IoT) devices, and intelligent terminals. Xinpletek's products are particularly relevant to 5G mobile communications, Narrowband IoT, and Wi-Fi technologies, catering to the growing demand for advanced wireless communication solutions.

Singular Medical

Series A in 2020
Singular Medical is a technology company specializing in R&D and industrialization of cardiac rhythm management (CRM) products. The company builds a complete technical platform and is a supplier of full line of CRM products, which provides a complete range of solutions, from detection to follow-up for large amounts of cardiac patients.

Hugo Biotech

Series A in 2020
Hugo Biotech has conducted the sequencing of nearly 20,000 clinical samples for over 300 first class hospitals in china.

Multitude Therapeutics

Venture Round in 2020
Multitude Therapeutics is a pharmaceutical company based in Xuhui, Shanghai, China, established in 2018. It specializes in the development of innovative drugs for the treatment of tumors, concentrating on novel antibody-drug conjugates (ADCs), CAR-T therapies, and immuno-oncology antibodies targeting both solid and hematological tumors. The company's therapeutic programs leverage unique cancer and immune cell surface targets identified through a proprietary technology known as the Human Membrane Proteome MabArray. This approach is supported by advanced antibody discovery capabilities developed at Abmart, allowing Multitude Therapeutics to offer a platform-based strategy for creating effective cancer treatments tailored to the needs of healthcare professionals.

SMEC

Venture Round in 2020
SMEC provides foundry services focusing on technology solutions for power, connection, and sensor signal chain.

Sinovation

Venture Round in 2020
Sinovation (Beijing) Medical Technology Co., Ltd. is a Beijing-based company that specializes in the research, development, production, and sale of medical devices. The company is dedicated to advancing medical robot technology and innovating intelligent medical products. Sinovation Medical's offerings include surgical robots that utilize clinical computer vision technology to enhance precision in medical procedures. These products are primarily designed for neurosurgical applications, addressing conditions such as epilepsy, Parkinson's disease, cerebral hemorrhage, and intracranial tumors. By providing reliable medical robotics, Sinovation aims to improve care for patients and support healthcare professionals in delivering effective treatment.

Polyvoly

Venture Round in 2020
Polyvoly is a beauty and personal care provider for the nourishment of the skin. It is designed and produces personal care products that are composed of essential oils and medicinal materials, enabling clients to nourish their skin and hair conditions. The company was founded in 2016 and is based in Wuhan, Hubei, China.

Boshi Medical

Venture Round in 2020
Boshi Medical engages in the research and development of ophthalmic medical devices. The company is headquartered in Nanjing, China.

HachiBot

Venture Round in 2020
HachiBot is a company based in Chaoyang District, Beijing, China, that designs and manufactures intelligent quadruped robots aimed at providing emotional companionship. Founded in 2019, HachiBot focuses on creating robots that enhance human self-realization and offer users companionship, care, and affection. The company's innovative approach seeks to address the emotional needs of individuals and families, making their products valuable for enhancing interpersonal connections and emotional well-being.

Belief Biomed

Venture Round in 2020
Belief Biomed brings the latest research achievements in precision medicine in Triangle area into production and promotes international collaboration by connecting established investors from China to explore the vast opportunity of North Carolina.

Yuanbao Insurance

Venture Round in 2020
Yuanbao Inc is a technology-driven online insurance distributor in China.

Habby

Venture Round in 2020
Publisher of mobile games intended to push globally for indie titles that can be enjoyed by all. The company provides various publishing services including product optimization, product design, tech assistance and market research, enabling game developers to create fun and distinctive games that actually benefit in real life by increasing certain skills or even educating in some way or another.

Colorlight

Venture Round in 2020
Colorlight Cloud Tech Ltd is engaged in the video processing algorithm as the core and hardware equipment as the carrier, it provides customers with professional display control products in the field of video images.

Bominwell Robotics

Series B in 2019
Shenzhen Bominwell Robotics Co., Ltd. designs and manufactures robots. It provides pipe inspection robots, such as wheeled military reconnaissance robots, crawler bomb disposal robots, and underground pipeline trajectory inertial navigation mapping robots, and pipe cloud platforms. The company also provides professional services, such as sonar detection, underwater detection, periscope detection, air-logged pipe issue, metamorphous pipe issue, and salty pipe issue detection services . Shenzhen Bominwell Robotics Co., Ltd. was founded in 2014 and is based in Shenzhen, China.

Micot

Seed Round in 2019
Shaanxi Micot Technology Co. Ltd specializes in the development of peptide drugs and innovative biopharmaceuticals. Founded in 2007 and based in Xi'an, China, the company focuses on creating treatments for various diseases, including cancer, cardiovascular, cerebrovascular, and neurological conditions. Micot's research includes the development of multi- and protein-based therapies, vaccines, and biomolecular drug delivery systems. Notably, the company has developed a unique biological macromolecular respiratory drug delivery system, Bio-Res-Deliv, which is designed for treating cardiovascular diseases, metabolic disorders, and liver diseases. Through its innovative approaches, Micot aims to advance drug screening and biopharmaceutical research.

Stellar Cyber

Series A in 2019
Stellar Cyber is an automated detection and response (Open-XDR) platform that correlates detections from existing solutions as well as its own security applications to deliver comprehensive protection across the cybersecurity kill chain and present them through one intuitive dashboard. Customers can leverage 20 native applications and a growing list of open ecosystem partners to detect and respond automatically to attacks within seconds wherever they occur on servers, in the network, at endpoints, or in cloud-based applications. Stellar Cyber deploys easily on premises, in public clouds or with service providers.

Yunyinggu

Series C in 2019
Yunyinggu Technology Co., Ltd. is a Chinese start-up focused on the development and promotion of innovative display technologies aimed at enhancing the performance of flat panel displays. The company has created a proprietary solution recognized for achieving superior pixel density, or high pixels per inch (PPI), which can be utilized across various types of flat panels, including LCD, LED, and OLED displays. By advancing display technology, Yunyinggu seeks to contribute to the evolving landscape of visual performance in consumer electronics.

Qihan Biotech

Series A in 2019
Qihan Biotech is a biomedical company specializing in genetic technology with a focus on xenotransplantation. The company aims to address the critical shortage of organ donors by utilizing advanced gene editing techniques to develop safe and effective cells, tissues, and organs for human transplantation. Their mission is to eliminate the waiting period associated with organ transplants, providing patients with access to life-saving organs. By harnessing cutting-edge genetic editing technology, Qihan Biotech seeks to create viable organs that can be transplanted into humans, thereby contributing to a solution for the global organ donor crisis.
It provides mobile enterprise resource planning(ERP) systems for sales, production and storage management.

AgotoZ

Series B in 2019
AgotoZ Technology (Beijing) Co., Ltd., established in 2017, specializes in designing and developing software-defined wide-area networks (SD-WAN) that enhance TCP acceleration, WAN connectivity, and network security. The company focuses on providing an intelligent network transmission platform that integrates resource calculation and security defense capabilities. AgotoZ employs independent research and development to advance its core technologies, which include high-speed WAN transmission, big data computing, and security solutions. By offering efficient and high-speed interoperability platforms and related products, AgotoZ aims to meet the diverse network transmission needs of enterprises, enhancing their operational efficiency and security. The company is based in Beijing, China, and is recognized as a leader in its field.

Huohua Logic

Series D in 2019
Huohua Siwei is an online education platform for K-12 children that specializes in Mathematics and Science. It offers a one-to-many online interactive live small class and strong interactive game links to develop students' core ability of thinking, concentration, and other core skills. It is focused on the young mathematics thinking training, which is divided into three modules: spatial thinking and graphics, computing power, and logical reasoning. The company was founded in 2017 and is headquartered in Beijing, China.

Kangpu Biopharmaceuticals

Series A in 2019
Kangpu is focused on developing small molecule drugs targeting immuno-modulating sites to develop treatments for cancer, autoimmune diseases and inflammation. The company has developed proprietary technologies to generate and degrade ubiquitin-protein. It also has a drug discovery combination platform called X-Synergy®.

LuxCreo

Series B in 2019
LuxCreo, founded in 2016, specializes in large-scale 3D printing manufacturing, encompassing software, hardware, and materials. The company offers a comprehensive 3D printing and software development platform that aims to enhance production efficiency in the manufacturing sector while simultaneously reducing costs for enterprises. LuxCreo develops innovative 3D printing equipment and provides services that include software and electronic hardware development, as well as material development. By leveraging advanced additive manufacturing techniques, LuxCreo addresses the growing demand for efficient and effective 3D printing solutions across various industries.

ServiceWall

Seed Round in 2019
ServiceWall is an e-commerce and financial scenario security service provider. It deploys front-end firewalls or post-data analysis services according to different business processes, mainly based on the local deployment of servers and software.

Xinpletek

Angel Round in 2019
Xinpletek is a company based in Shanghai, China, that specializes in the design and development of radio frequency (RF) front-end solutions. The firm focuses on RF technology research and development, providing a range of RF front-end modules for applications in mobile phones, Internet of Things (IoT) devices, and intelligent terminals. Xinpletek's products are particularly relevant to 5G mobile communications, Narrowband IoT, and Wi-Fi technologies, catering to the growing demand for advanced wireless communication solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.